Related Experiment Video
Updated: May 23, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Management of Helicobacter pylori-related disorders.
1Department of Gastroenterology and Nutrition, Central Middlesex Hospital, London, UK.
European Journal of Gastroenterology & Hepatology
|April 14, 2012
Summary
Eradicating Helicobacter pylori infection is now possible, offering a cure for chronic ulcer disease. Proton-pump inhibitor-based triple therapy is the current best treatment, effectively curing most infected patients.
Area of Science:
- Gastroenterology
- Microbiology
- Oncology
Background:
- Helicobacter pylori discovery revolutionized gastrointestinal disorder management.
- Chronic ulcer disease is now curable.
- National Institutes of Health (NIH) and Maastricht guidelines recommend H. pylori eradication therapy.
Purpose of the Study:
- To summarize updated guidelines for H. pylori eradication.
- To outline recommended therapeutic regimens.
- To highlight the efficacy of current treatments.
Main Methods:
- Review of NIH Consensus Conference (1994) and Maastricht Conference guidelines.
- Analysis of recommended patient groups for eradication therapy.
- Evaluation of proton-pump inhibitor-based triple therapy regimens.
Main Results:
- Updated guidelines strongly recommend H. pylori eradication for specific conditions including ulcers, MALT lymphoma, severe gastritis, and post-gastric cancer resection.
- Treatment is also suggested for functional dyspepsia, family history of gastric cancer, long-term PPI use, NSAID treatment, post-gastric surgery, and patient preference.
- Proton-pump inhibitor-based triple therapy (PPI plus two antibiotics) is the current optimal regimen.
Conclusions:
- H. pylori eradication is a key strategy in managing various gastrointestinal disorders.
- Proton-pump inhibitor-based triple therapy achieves high cure rates (85-95%) in a one-week course.
- Guidelines support broader application of H. pylori eradication therapy based on clinical evidence and patient factors.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...